Aspire Biopharma Holdings, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 05/12/2025 | 1.49 M | $101.13 K | 100.00% | 3.11% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 1.05 M | $71.09 K | 100.00% | 2.18% |
| SABA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 983.60 K | $71.80 K | 100.00% | 2.05% |
| LINDEN ADVISORS LP | 05/15/2025 | 900.00 K | $65.70 K | 100.00% | 1.87% |
| ARISTEIA CAPITAL LLC | 05/16/2025 | 681.52 K | $49.75 K | 100.00% | 1.42% |
| VERITION FUND MANAGEMENT LLC | 05/15/2025 | 432.76 K | $29.30 K | 100.00% | 0.90% |
| PERISCOPE CAPITAL INC. | 05/13/2025 | 408.57 K | $29.83 K | 100.00% | 0.85% |
| BARCLAYS PLC | 05/15/2025 | 350.00 K | $31.00 K | 100.00% | 0.73% |
| CLEAR STREET LLC | 05/15/2025 | 331.06 K | $22.41 K | 100.00% | 0.69% |
| TACONIC CAPITAL ADVISORS LP | 05/15/2025 | 300.00 K | $20.31 K | 100.00% | 0.62% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 275.00 K | $18.62 K | 100.00% | 0.57% |
| ALBERTA INVESTMENT MANAGEMENT CORP | 05/08/2025 | 250.00 K | $16.93 K | 100.00% | 0.52% |
| D. E. SHAW & CO., INC. | 05/15/2025 | 200.00 K | $13.54 K | 100.00% | 0.42% |
| WOLVERINE ASSET MANAGEMENT LLC | 05/12/2025 | 195.94 K | $13.27 K | 100.00% | 0.41% |
| CONTEXT CAPITAL MANAGEMENT, LLC | 05/05/2025 | 175.00 K | $11.85 K | 100.00% | 0.36% |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 05/15/2025 | 138.54 K | $10.11 K | 100.00% | 0.29% |
| LMR PARTNERS LLP | 05/15/2025 | 125.00 K | $8.46 K | 100.00% | 0.26% |
| WHITEBOX ADVISORS LLC | 05/15/2025 | 118.75 K | $8.04 K | 100.00% | 0.25% |
| CLEAR STREET DERIVATIVES LLC | 05/15/2025 | 106.00 K | $7.18 K | 100.00% | 0.22% |
| JPMORGAN CHASE & CO | 05/12/2025 | 100.00 K | $6.77 K | 100.00% | 0.21% |
| CAAS CAPITAL MANAGEMENT LP | 05/01/2025 | 75.00 K | $5.08 K | 100.00% | 0.16% |
| BLUE OWL CAPITAL HOLDINGS LP | 05/15/2025 | 50.00 K | $3.50 K | 100.00% | 0.10% |
| PICTON MAHONEY ASSET MANAGEMENT | 05/07/2025 | 50.00 K | $3.00 K | 100.00% | 0.10% |
| MINT TOWER CAPITAL MANAGEMENT B.V. | 05/15/2025 | 25.00 K | $15.00 K | 100.00% | 0.05% |
| OMERS ADMINISTRATION CORP | 05/14/2025 | 25.00 K | $1.83 K | 100.00% | 0.05% |
| ATHOS CAPITAL LTD | 05/14/2025 | 21.38 K | $12.00 K | 100.00% | 0.04% |
| FLOW TRADERS U.S. LLC | 05/14/2025 | 14.19 K | $1.00 K | 100.00% | 0.03% |
| 05/01/2025 | 70 | $4 | 100.00% | 0.00% | |
| FARTHER FINANCE ADVISORS, LLC | 04/14/2025 | 10 | $1 | 100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aspire Biopharma Holdings, Inc. institutional Ownership - FAQ's
During the previous two years, 27 institutional investors and hedge funds held shares of Aspire Biopharma Holdings, Inc.. The most heavily invested institutionals were:
Farther Finance Advisors, LLC: 0
HIGHBRIDGE CAPITAL MANAGEMENT LLC: 1.49 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 1.05 M
Saba Capital Management, L.P.: 983,603
LINDEN ADVISORS LP: 899,999
ARISTEIA CAPITAL LLC: 681,516
17.89% of Aspire Biopharma Holdings, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 8.60 M shares in the last 24 months. This purchase volume represents approximately $430.05 K in transactions.